333 related articles for article (PubMed ID: 27343996)
1. Structural insights into the centronuclear myopathy-associated functions of BIN1 and dynamin 2.
Hohendahl A; Roux A; Galli V
J Struct Biol; 2016 Oct; 196(1):37-47. PubMed ID: 27343996
[TBL] [Abstract][Full Text] [Related]
2. Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.
Fujise K; Noguchi S; Takeda T
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682949
[TBL] [Abstract][Full Text] [Related]
3. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
[TBL] [Abstract][Full Text] [Related]
4. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
[TBL] [Abstract][Full Text] [Related]
5. Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy.
Fujise K; Okubo M; Abe T; Yamada H; Nishino I; Noguchi S; Takei K; Takeda T
J Biol Chem; 2021; 296():100077. PubMed ID: 33187981
[TBL] [Abstract][Full Text] [Related]
6. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.
Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J
Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181
[TBL] [Abstract][Full Text] [Related]
7. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
[TBL] [Abstract][Full Text] [Related]
8. [Mutations in amphiphysin 2 (BIN1) cause autosomal recessive centronuclear myopathy].
Toussaint A; Nicot AS; Mandel JL; Laporte J
Med Sci (Paris); 2007 Dec; 23(12):1080-2. PubMed ID: 18154705
[No Abstract] [Full Text] [Related]
9. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.
Gineste C; Simon A; Braun M; Reiss D; Laporte J
Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127
[TBL] [Abstract][Full Text] [Related]
10. Dominant Centronuclear Myopathy with Early Childhood Onset due to a Novel Mutation in BIN1.
Kouwenberg C; Bohm J; Erasmus C; van Balken I; Vos S; Kusters B; Kamsteeg EJ; Biancalana V; Koch C; Dondaine N; Laporte J; Voermans N
J Neuromuscul Dis; 2017; 4(4):349-355. PubMed ID: 29103045
[TBL] [Abstract][Full Text] [Related]
11. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation.
Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW
Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319
[TBL] [Abstract][Full Text] [Related]
12. Mutations in BIN1 associated with centronuclear myopathy disrupt membrane remodeling by affecting protein density and oligomerization.
Wu T; Shi Z; Baumgart T
PLoS One; 2014; 9(4):e93060. PubMed ID: 24755653
[TBL] [Abstract][Full Text] [Related]
13. Centronuclear myopathies: a widening concept.
Romero NB
Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
[TBL] [Abstract][Full Text] [Related]
14. Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy.
Böhm J; Vasli N; Maurer M; Cowling BS; Shelton GD; Kress W; Toussaint A; Prokic I; Schara U; Anderson TJ; Weis J; Tiret L; Laporte J
PLoS Genet; 2013 Jun; 9(6):e1003430. PubMed ID: 23754947
[TBL] [Abstract][Full Text] [Related]
15. Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation.
Cowling BS; Prokic I; Tasfaout H; Rabai A; Humbert F; Rinaldi B; Nicot AS; Kretz C; Friant S; Roux A; Laporte J
J Clin Invest; 2017 Dec; 127(12):4477-4487. PubMed ID: 29130937
[TBL] [Abstract][Full Text] [Related]
16. N-WASP is required for Amphiphysin-2/BIN1-dependent nuclear positioning and triad organization in skeletal muscle and is involved in the pathophysiology of centronuclear myopathy.
Falcone S; Roman W; Hnia K; Gache V; Didier N; Lainé J; Auradé F; Marty I; Nishino I; Charlet-Berguerand N; Romero NB; Marazzi G; Sassoon D; Laporte J; Gomes ER
EMBO Mol Med; 2014 Nov; 6(11):1455-75. PubMed ID: 25262827
[TBL] [Abstract][Full Text] [Related]
17. Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy.
Gómez-Oca R; Edelweiss E; Djeddi S; Gerbier M; Massana-Muñoz X; Oulad-Abdelghani M; Crucifix C; Spiegelhalter C; Messaddeq N; Poussin-Courmontagne P; Koebel P; Cowling BS; Laporte J
Nat Commun; 2022 Nov; 13(1):6849. PubMed ID: 36369230
[TBL] [Abstract][Full Text] [Related]
18. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of membrane tubulation coupled with fission by a two-component module.
Bhattacharyya S; Pucadyil TJ
Proc Natl Acad Sci U S A; 2024 May; 121(20):e2402180121. PubMed ID: 38717859
[TBL] [Abstract][Full Text] [Related]
20. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.
James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM
Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]